133 related articles for article (PubMed ID: 15463863)
1. Exhaled nitric oxide increases following admission for intravenous antibiotics in children with cystic fibrosis.
Jaffé A; Slade G; Rae J; Laverty A
J Cyst Fibros; 2003 Sep; 2(3):143-7. PubMed ID: 15463863
[TBL] [Abstract][Full Text] [Related]
2. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.
Robinson PD; Cooper P; Van Asperen P; Fitzgerald D; Selvadurai H
Pediatr Pulmonol; 2009 Aug; 44(8):733-42. PubMed ID: 19598271
[TBL] [Abstract][Full Text] [Related]
3. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.
Keen C; Gustafsson P; Lindblad A; Wennergren G; Olin AC
Pediatr Pulmonol; 2010 Mar; 45(3):241-8. PubMed ID: 20146368
[TBL] [Abstract][Full Text] [Related]
4. Dornase alpha and exhaled NO in cystic fibrosis.
Grasemann H; Lax H; Treseler JW; Colin AA
Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350
[TBL] [Abstract][Full Text] [Related]
5. Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis.
Zetterquist W; Marteus H; Kalm-Stephens P; Näs E; Nordvall L; Johannesson M; Alving K
Respir Med; 2009 Feb; 103(2):187-93. PubMed ID: 19006660
[TBL] [Abstract][Full Text] [Related]
6. Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations.
Antus B; Barta I; Horvath I; Csiszer E
Respirology; 2010 Apr; 15(3):472-7. PubMed ID: 20210889
[TBL] [Abstract][Full Text] [Related]
7. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
[TBL] [Abstract][Full Text] [Related]
8. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
9. Reliability of a new hand-held device for the measurement of exhaled nitric oxide.
Khalili B; Boggs PB; Bahna SL
Allergy; 2007 Oct; 62(10):1171-4. PubMed ID: 17845587
[TBL] [Abstract][Full Text] [Related]
10. Comparing 6 and 10 sec exhalation time in exhaled nitric oxide measurements in children.
Koopman M; Arets HG; Uiterwaal CS; van der Ent CK
Pediatr Pulmonol; 2009 Apr; 44(4):340-4. PubMed ID: 19291761
[TBL] [Abstract][Full Text] [Related]
11. Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults.
Hofer M; Mueller L; Rechsteiner T; Benden C; Boehler A
Lung; 2009; 187(5):307-13. PubMed ID: 19669109
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.
Enderby B; Smith D; Carroll W; Lenney W
Pediatr Pulmonol; 2009 Feb; 44(2):142-7. PubMed ID: 19148935
[TBL] [Abstract][Full Text] [Related]
13. Increased arginase activity in cystic fibrosis airways.
Grasemann H; Schwiertz R; Matthiesen S; Racké K; Ratjen F
Am J Respir Crit Care Med; 2005 Dec; 172(12):1523-8. PubMed ID: 16166623
[TBL] [Abstract][Full Text] [Related]
14. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
15. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
16. Comparability of a hand-held nitric oxide analyser with online and offline chemiluminescence-based nitric oxide measurement.
Schiller B; Hammer J; Barben J; Trachsel D
Pediatr Allergy Immunol; 2009 Nov; 20(7):679-85. PubMed ID: 19682277
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.
Ojoo JC; Mulrennan SA; Kastelik JA; Morice AH; Redington AE
Thorax; 2005 Jan; 60(1):22-6. PubMed ID: 15618578
[TBL] [Abstract][Full Text] [Related]
18. The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children.
Gabriele C; Pijnenburg MW; Monti F; Hop W; Bakker ME; de Jongste JC
Pediatr Allergy Immunol; 2005 May; 16(3):243-7. PubMed ID: 15853954
[TBL] [Abstract][Full Text] [Related]
19. Exhaled and nasal nitric oxide in relation to lung function, blood cell counts and disease characteristics in cystic fibrosis.
Krantz C; Janson C; Hollsing A; Alving K; Malinovschi A
J Breath Res; 2017 Mar; 11(2):026001. PubMed ID: 28220034
[TBL] [Abstract][Full Text] [Related]
20. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
